A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers. [electronic resource]
Producer: 20170606Description: 1484-91 p. digitalISSN:- 1525-0024
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Combined Modality Therapy
- Female
- Gene Transfer Techniques
- Genetic Therapy -- adverse effects
- Humans
- Liposomes
- Male
- Middle Aged
- Molecular Targeted Therapy
- Nanomedicine -- methods
- Neoplasm Metastasis
- Neoplasm Staging
- Plasmids -- administration & dosage
- Receptors, Transferrin -- immunology
- Retinoblastoma Protein -- genetics
- Single-Chain Antibodies -- genetics
- Tomography, X-Ray Computed
- Transgenes
- Treatment Outcome
- Urogenital Neoplasms -- diagnosis
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.